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Abstract
Background and Objective: Systemic chronic inflammation is linked to metabolic syndrome, type-2 diabetes, and
heart disease. Lipopolysaccharide (LPS), a Gram negative microbial product, triggers inflammation through toll-like-
receptor-4 (TLR-4) signaling. It has been reported that dietary fatty acids also modulate inflammation through TLR-
4. We investigated whether fish oil (FO) rich diet in comparison to saturated fat (SF) rich diet would confer
protection from pathologies induced by LPS.
Methods: Twenty C57BL/6 mice were divided into two groups. One group received FO-diet and other received
SF-diet ad libitum for 60 days. Diets were isocaloric containing 45% energy from fat. After 60-days of feeding, blood
was collected after overnight fast. Mice were allowed to recover for 4-days, fasted for 5-hours, challenged with 100
ng/mL of LPS intraperitonially, and bled after 2-hours. After 7-days of recuperation, mice were challenged with 500
ng/mL of LPS intraperitonially and observed for physical health.
Results: Food intake was similar in FO- and SF-fed mice. FO-fed mice compared to SF-fed mice had significantly
less body weight gain (P = 0.005), epididymal fat weight (P = 0.005), fasting blood glucose (70.8 vs 83.3 ng/dL; P <
0.05), HOMA-IR (5.0 vs 13.6; P < 0.019), and serum cholesterol (167 vs 94 mg/dL; P < 0.05). When challenged with
LPS, FO-fed mice had significantly lower serum IL-1b compared to SF-fed mice (2.0 vs 30.0 pg/mL; P < 0.001). After
LPS-challenge, SF-fed mice had higher mortality, lost more body weight, and had greater decrease in blood
glucose compared to FO-fed mice.
Conclusion: Overall, FO-diet compared to SF-diet offered protection against deleterious effects of LPS in mice.
Introduction
Although inflammation is part of the body’sn o r m a l
response to infection and injury, extreme or inappropri-
ate inflammation is linked to the pathobiology of several
diseases [1]. Systemic low-grade chronic inflammation
plays a major role in the pathogenesis of insulin resis-
tance, metabolic syndrome, obesity, type 2 diabetes mel-
litus (DM2), and cardiovascular disease (CVD) [2-5].
Consequently, persons with obesity, DM2, and CVD
experience increased markers of inflammation compared
to their counterparts [6].
Toll-like-receptors (TLR) play an important role in the
regulation of innate immunity [7-9] by detecting most
pathogens such as bacteria, fungi, and viruses [10]. Toll-
like-receptor-4 (TLR-4) is a subclass of the TLR family
involved in activation of the innate immune and inflam-
matory response in mammals [9-11] via ligation of
lipopolysaccharide (LPS), a Gram-negative bacterial
endotoxin found on the outer cell membrane of bac-
teria. Activation of TLR-4 leads to the induction of
genes for many inflammatory cytokines [9,12-14]. These
cytokines are involved in inducing insulin resistance,
glucose intolerance, and infiltration of macrophages into
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duction of inflammatory markers [15-17]
Increased intake of saturated fat (SF) is linked to dysli-
pidemia and adiposity, which are further related to
increased risk for DM2 and CVD [18]; while n-3 fatty
acids present in fish oil (FO) are linked to decreased
risk for these diseases [19]. However, the exact molecu-
lar mechanism linking dietary fatty acids with obesity,
DM2, and CVD is not well understood. Recently, in
vitro experiments have shown that TLR-4 responds to
nonbacterial ligands such as lauric acid (a saturated fatty
acid) and n-3 fatty acids such as eicosapentaenoic acid
(EPA) and docosahexaenoic acid (DHA) [20-22].
Further, it has been shown that TLR-4 deficiency pro-
tects mice from inflammation, insulin resistance, and
increased adiposity in mice fed a diet high in SF [23]. It
is likely that TLR-4 is a possible link between dietary
fatty acids and inflammation, insulin resistance, and
DM2. In vivo studies are limited linking dietary fatty
acids with TLR-4 signaling and inflammation, insulin
resistance, and adiposity. Also, it is not known if FO
rich diet offers protection against the TLR-4 agonist,
LPS in vivo. Greater understanding of the role of TLR-4
in relation to dietary fat is important in understanding
the pathobiology of insulin resistance and DM2. There-
fore, the objective of this study was to investigate
whether a diet rich in FO of marine origin in relation to
a diet rich in SF would offer protection against endotox-
emia (LPS)-induced pathologies in C57BL/6 mice.
Methods
Animals and facilities
Approval for the use of mice was obtained from the
Institutional Animal Care and Use Committees of
Emory University and Georgia State University, Atlanta,
GA. Twenty, 4-week old male C57BL/6 mice were pur-
chased from Jackson Laboratories (Bar Harbor, Maine,
ME). All mice were housed in metal barred cages with
bedding (5 mice/cage). Sufficient amounts of bedding
were used to keep animals clean and dry between cage
changes and to prevent odors. Animals had 12 hour
light and dark cycles. Bedding changes, along with
cleaning and sanitation of cages and associated equip-
ment, such as watering devices, were performed as often
as necessary.
Diets and treatments
After arrival, mice went through a 4-day acclimatization
period. During this period, mice were fed a regular
chow diet. Twenty mice were randomly divided into two
groups of 10 mice each. Diets rich in FO (product #
D08092503) and SF (product # D05122102P) were pur-
chased from Research Diets, Inc. (New Brunswick, NJ).
Type of fat in FO and SF diets were menhaden oil and
lard, respectively. The diets were isocaloric and con-
tained 45% energy from total fat (Table 1). Enough food
was provided for mice to eat ad libitum for 2 days.
After this time, any unconsumed food was thrown away
after weighing and the amount of food eaten were
quantified.
Study design
Mice received FO and SF diets for 60 days. At the end
of 60-days, all mice were fasted overnight and blood was
collected using the retro-orbital method while mice
were under isoflurane anesthesia. Following a 4-day
recovery, both groups were fasted for 5-hours, chal-
lenged with 100 ng of LPS intraperitonially, and bled 2-
hours post LPS-challenge. Then mice were allowed to
recover for 7 days from the 100 ng LPS challenge. Fol-
lowing the recovery, mice were fasted for 5-hours, chal-
lenged with 500 ng of LPS intraperitoneally, After 2
hours, mice were then euthanized using carbon dioxide
and epididymal fat, liver, colon, and cecum were har-
vested. Following 100 ng and 500 ng LPS challenges,
mice were observed for any physical abnormalities
including for mortality. During recovery phases, mice
were fed their respective diets. Body weights were
recorded on a weekly basis, at the end of 60-day period,
and at the end of LPS challenge.
Reagents and biochemical analysis
Hemolysis-free serum was generated by centrifugation of
blood using serum separator tubes (Becton Dickinson,
Franklin Lakes, NJ). Serum was stored at -80°C until
Table 1 Composition of experimental diets
Ingredient Fish oil-based diet
1 Saturated fat-based diet
2
g (%) Kcal g (%) Kcal (%)
Protein 23.7 20 23.7 20
Carbohydrate 41.4 35 41.4 35
Fat
1 23.6 45 23.6 45
Casein 200 (23.3) 800 200 (23.3) 800
L-Cystine 3 (0.35) 12 3 (0.35) 12
Corn starch 72.8 (9.88) 291 72.8 (9.88) 291
Maltodextrin 100 (11.65) 400 100 (11.65) 400
Sucrose 172.8 (20.14) 691 172.8 (20.14) 691
Cellulose 50 (5.83) 0 50 (5.83) 0
Soybean Oil 25 (2.91) 225 25 (2.91) 225
Lard 0 0 177.5 (20.68) 1598
Menhaden oil 177.5 (20.68) 1598 0 0
Mineral mix 10 (1.17) 0 10 (1.17) 0
Vitamin mix 10 (1.17) 40 10 (1.17) 40
Choline bitartrate 2 (0.23) 0 2 (0.23) 0
Cholesterol 0.17 (0.02) 0 0.71 (0.08) 0
Total 858.2 4057 858.2 4057
1Source fish oil was menhaden oil.
2Source saturated fat was lard.
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CBC-Diff Veterinary Hematology System (Heska, Love-
land, CO). Concentrations of IL-1b, IL-6, TNF-a, kerati-
nocyte chemoattractant (KC), fasting blood glucose,
serum insulin, and serum leptin were measured at the
end of 60-days and after 100 ng of LPS challenge. IL-1b,
IL-6, TNF-a, and KC were all analyzed using ELISA kits
following manufacturer instructions. ELISA kits for
serum IL-1b (catalog # DY401), IL-6 (catalog # DY406),
TNF-a (catalog # DY410), and KC (catalog # DY453)
were purchased from R&D Systems, Minneapolis, MN.
Fasting blood glucose was analyzed with Accu-Check
Advantage blood glucose meter (Roche, Florence, SC)
by using blood from the tail vein. Serum insulin and
leptin concentrations were analyzed using ELISA kits
purchased from Linco Research Inc (St. Charles, MO).
Escherichia coli LPS 0111:B6 was purchased from
Sigma-Aldrich (St. Louis, MO). Homeostatic Model
Assessment-Insulin Resistance (HOMA-IR) was calcu-
lated from insulin and glucose concentrations (fasting
insulin (μU/mL) × fasting glucose (mg/dL)/405).
Data analysis
The statistical analysis was performed using GraphPad
Prism Software (Version 5.0, La Jolla, CA). Normality
tests were done, after which parametric (unpaired t-test)
or nonparametric (Mann-Whitney U) tests were used to
analyze the differences between diets. The difference
between pre- and post-LPS-treatment values within the
diet group was analyzed with paired t-test for normal
data or with Wilcoxin Sign test for nonnormal data.
Mortality rate between SF and FO diets after the 100 ng
and 500 ng LPS-challenge was analyzed with Fisher’s
exact test. Statistical significance was set at P ≤ 0.05.
Results
Effects of FO and SF diets, after LPS-challenge on food
intake and body and tissue weights
Total food intake during the 60-day period was not sig-
nificantly different between mice that received FO and
SF diet (P = 0.60). Average body weight changes for FO
and SF diet groups are presented in Figure 1. Although
there was no significant difference in body weights
between SF and FO diet groups at the end 60 day per-
iod (28.2 vs. 26.8 g; P < 0.186), the net weight gain was
significantly higher with SF diet compared to FO diet
(15.6 g vs. 13.3 g; P = 0.005) (Table 2). Epididymal fat
was significantly increased in mice that received SF diet
compared to mice that received FO diet (0.61 g vs. 0.45
g) (P = 0.005). Of organ weights at necropsy, colon
weight were significantly lower in SF diet group com-
pared to FO diet group (P < 0.013) Cecum and liver
weights were not significantly different between two diet
groups (Table 2).
Effect of FO and SF diets, after LPS-challenge on overall
well-being and mortality of mice
Mice that received SF diet in comparison to FO diet were
moribund. After LPS-challeng e ,m i c et h a tr e c e i v e dS F
diet exhibited less or no nesting behavior. After 100 ng
LPS challenge, 1 mouse died in SF diet group but none in
the FO diet group. After 500 ng LPS challenge, 1 mouse
died in FO diet group and 3 mice died in SF diet group.
H o w e v e r ,t h em o r t a l i t yr a t eb e t w e e nS Fa n dF Od i e t s
after 500 ng LPS-challenge was not significant in Fisher’s
exact test. After LPS challenge, mice in SF diet group
compared to FO diet group had significantly more weight
loss (-0.63 g vs. -0.22 g; P < 0.009) (Figure 2A).
Figure 1 Effects of fish oil (FO) and saturated fat (SF) diets on
weight gain in C57BL/6 mice by week. Data points represent
mean (n = 10). At the end of the 60 day feeding period, the end
mean weights were not significantly different between SF and FO
diet groups (28.2 vs. 26.8 g; P < 0.086). Significant differences were
tested with Man-Whitney U test.
Table 2 The effect of fish oil and saturated fat on body
and tissue weights
1
Fish oil diet Saturated fat diet P-value
End point body weight,
2 g 26.8 ± 0.37 28.2 ± 0.64 0.19
Net weight gain,
3 g 13.3 ± 0.47 15.6 ± 0.53
4 0.005
Tissue weight
5
Epididymal fat, g 0.45 ± 0.02 0.61 ± 0.74
4 0.005
Colon, g 0.15 ± <0.01 0.12 ± 0.01
4 < 0.013
Cecum, g
Liver, g
0.19 ± 0.01
1.01 ± 0.03
0.23 ± 0.02
0.99 ± 0.05
0.26
0.1
1Data are presented as mean ± SE
2Measured after 60 day feeding period
3 Difference between 60 day feeding period weights and pre-study values
4Significantly different form saturated fat diet
5Weights, after 2 hours post 500 ng LPS-challenge
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insulin, and HOMA-IR
To investigate the effect of TLR-4 signaling on glucose
metabolism, we injected LPS, the classic TLR-4 agonist,
intraperitonially at a low dose of 100 ng/mouse. To
investigate the impact of FO diet in comparison with SF
diet on glucose metabolism, we tested blood glucose
concentrations after a 12-hour overnight fast at the end
of 60 day feeding. FO diet group had significantly lower
overnight fasting blood glucose concentrations com-
pared to SF diet group (70.8 mg/dL vs 83.3 mg/dL) (P <
0.014) (Figure 2B). Both groups of mice showed a signif-
icant drop in blood glucose concentrations after LPS-
challenge. However, no significant difference was
observed in blood glucose between FO- and SF-fed mice
after LPS- challenge (Figure 2C). A greater decrease in
blood glucose concentration was observed with SF diet
compared to FO diet after 100 ng of LPS challenge
(89.2 mg/dL vs 30.9 mg/dL; P < 0.03) (Figure 2D).
After administration of 100 ng of LPS, SF-fed mice
had a higher mean insulin concentration compared to
FO-fed mice (2.11 vs. 0.88 ng/mL) (Figure 3A). How-
ever, these values were not significant (P < 0.06). We
calculated HOMA-IR scores from fasting blood glucose
and insulin concentrations to assess whether FO diet
protected mice from IR. In fact, mice that received FO
diet had significantly lower HOMA-IR scores compared
to mice that received SF diet after 60-day feeding (5.0
vs. 13.6; P < 0.019) and after LPS-challenge (4.43 vs.
14.23; P < 0.04) (Figure 3B).
Figure 2 Effect of fish oil (FO)and saturated fat (SF) diets on lipopolysaccharide (LPS)-induced body weight (A), overnight fasting (B),
plasma glucose (C), and blood glucose drop (D). Body weight loss (A) calculation was based on weight changes between body weight at
the end of 60 day period and body weight at the end of 7 day recovery post 100 ng LPS challenge (n = 6). Overnight fasting (12 h) blood
glucose concentrations of mice fed FO and SF diets at the end of 60 day are shown in B (n = 10). Blood glucose (C) and blood glucose drop (D)
for mice that received FO and SF diets before and after LPS-challenge (n = 5-9). Blood glucose drop was calculated based on blood glucose
between pre- and post-100 ng LPS-challenge (n = 5). Significant differences were tested either with unpaired/paired t-test or with Man-Whitney
U test/Wicoxin Sign test. Values are means ± SE. Only significant comparisons are presented.
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cholesterol, leptin, and cytokines
After 60 days of feeding, FO diet group had significantly
lower serum cholesterol concentrations when compared
to SF diet group (97.6 mg/dL vs 183 mg/dL) (P <0 . 0 1 ) .
As expected, SF diet was hypercholesterolemic compared
to FO diet after 60 days of feeding (P < 0.001). These dif-
ferences persisted between SF and FO diets even after
LPS challenge. LPS administration had no impact on
serum cholesterol (Figure 4A ) .T h e r ew a sn od i f f e r e n c e
in mean serum leptin between the FO and SF diet groups
at baseline or after LPS-challenge (Figure 4B).
Figure 3 Effect of fish oil (FO) and saturated fat (SF) diets on serum insulin (A) and Homeostatic Model Assessment-Insulin Resistance
(HOMA-IR) (B) before and after 100 ng lipopolysaccharide (LPS)-challenge in C57BL/6 mice (n = 5-10). Serum insulin (A) and HOMA-IR (B)
for mice that received FO and SF diets before and after LPS-challenge (n = 5-9). Significant differences were tested either with unpaired/paired t-
test or with Man-Whitney U test/Wicoxin Sign test. Values are means ± SE. Only significant comparisons are presented.
Figure 4 Effect of fish oil and saturated fat diets on concentrations of serum cholesterol (A) and leptin (B) before and after 100 ng
lipopolysaccharide-challenge in C57BL/6 mice (n = 5-10). Values are means ± SE. Significant differences were tested either with unpaired/
paired t-test or with Man-Whitney U test/Wicoxin Sign test. Only significant comparisons are presented.
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mean serum IL-1b concentrations compared to those
that received FO diet after 100 ng LPS-challenge (30.0
pg/mL vs. 2.0 pg/mL) (P = 0.0004) (Figure 5A). As
expected, with LPS-challenge, both in FO- and SF-fed
mice had significantly higher concentrations of inflam-
matory markers such as serum TNF-a and KC. How-
ever, mean serum concentrations of KC (Figure 5B),
TNF-a (Figure 5C), and IL-6 (data not shown) were not
significantly different between mice that received FO
and SF diets either at pre-LPS-challenge or post- LPS
challenge.
Discussion
To our knowledge, this is the first study that reported
the protective effect of a diet rich in FO in relation to a
diet rich in SF against LPS-induced pathologies in mice
with functional TLR-4. SF-fed mice that were challenged
with LPS got sicker and had higher mortality rate com-
pared to FO-fed mice. After LPS challenge, SF-fed mice
lost more weight and had greater drop in blood glucose
concentrations compared to FO-fed mice. These coin-
cided with higher serum IL-1b concentrations in SF-fed
mice challenged with LPS compared to their counter-
parts. Additionally, net body weight gain, abdominal fat
weight, serum cholesterol, and blood glucose were sig-
nificantly higher in SF-fed mice compared to FO-fed
mice.
Although the food intake during the 60 day feeding
was not significantly different between FO- and SF-fed
mice, the net body weight gain and epididymal fat
weight were significantly increased in SF-fed mice sug-
gesting that the weight gain observed in SF-fed mice
was due to type of fat administered and not due to
Figure 5 Effect of fish oil and saturated fat diets on concentrations of serum IL-1b (A), KC (B), and TNF-a (C) before and after 100 ng
lipopolysaccharide-challenge in C57BL/6 mice (n = 5-10). Values are means ± SE. Significant differences were tested either with unpaired/
paired t-test or with Man-Whitney U test/Wicoxin Sign test. Only significant comparisons are presented.
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elevated inflammation and further fat intake/infusion is
likely to lead elevated free fatty acids which further
leads to elevated inflammation [24-26]. Intake of n-3
fatty acids from marine sources reduces adiposity by
inhibiting the sterol regulatory element binding protein-
1 and thereby decreasing the expression of lipogenic
genes (acetyl CoA carboxylase and fatty acid synthase),
increasing the gene expression of lipolytic genes (hor-
mone sensitive lipase and serum amyloid A) [27], and
decreasing expression of perilipin, a lipid droplet-protec-
tive protein [28]. Similar to our findings, Samane et al
[29] found that FO decreased visceral adiposity com-
pared to a diet rich in lard. They also reported no differ-
ence in weight gain between mice fed a high fat diet
with 6% of fat replaced by fish oil or argan oil (mainly
oleic acid) for 4 weeks, suggesting the effect of fish oil
on body weight is affected by the duration and amount
of fish oil intake.
Another beneficial effect of FO diet in relation to SF
diet is decreased circulating cholesterol. After 60-day
feeding, on average, mice fed FO diet had 87.5% lower
serum cholesterol compared to mice fed SF diet.
Depressed circulating cholesterol is a well established
cardioprotective factor [30]. Generally, decreased blood
cholesterol is due to lowered LDL cholesterol. It has
been well documented diets rich in FO are cardioprotec-
tive [31,32]. However, effects of FO on blood lipids have
not been uniform [30]. Chang et al [32] reported that
the cardioprotective effect of FO in comparison to SF
diet was not related to blood cholesterol. In their study,
SF and FO diets had similar increase in blood choles-
terol but free fatty acids and triglycerdes were lower
with FO diet in relation to SF diet. Increased blood cho-
lesterol was likely due to higher cholesterol content of
SF and FO diets [32]. Additionally, cardioprotective
effect of n-3 fatty acids compared to SF was due to
reduced total LDL uptake and cholesterol ester deposi-
tion in arterial walls [32,33].
Studies have shown that diets high in fat (other than
FO) and specifically high in SF induced metabolic endo-
toxemia and adipose tissue inflammation by altering gut
microbiota and permeability to LPS [34-36] and by sti-
mulating TLR-4 expression [37]. Antibiotic treatment
reversed these effects significantly [34]. Thus metabolic
endotoxemia (increased circulating LPS) may partly
explain the increased inflammation with SF diet. In our
study, the SF diet group had a significant decrease in
colon weight compared to FO diet group (P < 0.013).
This decrease in colon weight observed in the SF group
may be a result of atrophy due to a change in the intest-
inal microbiota or increased colon weight in FO diet
group due to protective effect of FO on the gut. More
research investigating the effect of saturated fat and n-3
fatty acids on intestinal microbiota and pathobiology of
gut is needed to verify this observation.
After administration of LPS, mice were observed for
changes in behavior. In the post-500 ng LPS phase, 3
mice died in the SF group out of 9 (33.3% mortality
r a t e )a n d1m o u s ed i e do u to f1 0( 1 0 %m o r t a l i t yr a t e )
in the FO group suggesting that FO offered protection
against LPS-induced sickness and mortality. Further-
more, after LPS-challenge, SF-fed mice had lost more
body weight and experienced a greater decline in
blood glucose (decrease was 42.8% with SF and 19.7%
with FO) than FO-fed mice suggesting that the SF-fed
mice were in a more catabolic state. Following the 60
day period, we noticed no overt in-between group dif-
ferences in the physical appearance of mice. However,
following 100 ng LPS-challenge, the SF diet group
mice became reclusive and shortly fell asleep. In con-
trast, the FO-fed mice exhibited no abnormal behavior.
After the 500 ng LPS-challenge, both groups of mice
were moribund. However, mice in FO diet group
recovered quicker (within 30 minutes) than the mice
in SF diet group. These observations illustrate an over-
all protective effect of fish oil from LPS-induced ill
health.
After 60 days of feeding, FO diet group had a 17.7%
decrease in fasting blood glucose compared to SF diet
group (P < 0.01) suggesting overall protection of FO
from hyperglycemia. Flachs P et al [38] reported a ≈4%
decrease in blood glucose in mice fed a FO diet. Ross-
meisl et al [39] reported a blood glucose decrease of
≈19.2% in mice fed DHA diet compared to mice fed a
corn oil diet for 4 months. In contrast, Samane et al
[29] reported no significant decrease in fasting blood
glucose. It is likely that the differences in results in
between these studies may be due to differences in
duration of feeding and amount of FO present in experi-
mental diets.
Although insulin concentration did not reach statistical
significance, there was higher insulin concentration in SF
group compared to FO group after mice were challenged
with LPS (P < 0.06). FO diet group compared to SF diet
group had lower HOMA-IR values after 60 day feeding
and after LPS challenge. The observation of improved
insulin sensitivity in rodents fed FO diet compared to
rodents fed SF diet has been previously reported [39].
Differential effects of saturated and n-3 fatty acids on
TLR-4 signaling may explain the variation in insulin
resistance. Saturated fatty acids and LPS induce dimeriza-
tion and recruitment of TLR-4 to the membrane which
are essential for TLR-4 signaling. In contrast, DHA of FO
inhibits the dimerization and recruitment of TLR-4 into
the membrane [40] leading to attenuated TLR-4 signal-
ing. In vivo studies have reported that FO is incorporated
into the plasma membrane where it inhibits downstream
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resistance [43-45].
Obesity and DM2 are characterized by elevated cir-
culating concentrations of inflammatory markers [46].
T h e s ei n f l a m m a t o r ym a r k e rs originate from adipose
tissue [47]. In diet-induced obesity, macrophages infil-
trate into white adipose tissue and these infiltrated
macrophages produce inflammatory markers such as
IL-1b [48,49]. We found a protective effect of FO
against IL-1b, a potent inflammatory marker, in LPS-
challenged mice. Several studies have demonstrated
that consumption of FO decreased production of IL-1b
from mononuclear cells [50-52]. Eevated IL-1b pro-
motes insulin resistance [53]. IL-1b is produced from
large pro-inflammatory protein complexes called
inflammasomes [54]. These are part of innate immune
system activated by various microbial stimuli. Other
mechanisms through which FO exerts anti-inflamma-
tory properties include displacement of arachidonic
acid in the plasma membrane leading to the synthesis
of anti-inflammatory PGE3 and LTB5 instead of PGE2
and LTB4, respectively [55]. Recent studies revealed
that n-3 fatty acids produce E- and D-series resolvins
[56-58] which are found to be potently anti-inflamma-
tory [59].
There is a possibility that the overall beneficial effect
of FO against LPS-induced ill health that we found in
our study may also be due to mechanisms unrelated to
TLR-4 and NRLs. Although n-3 fatty acids from FO are
known to antagonize the effects of LPS-induced TLR-4
signaling, the protection of FO diet could potentially be
due to increased production of anti-inflammatory com-
ponents of n-3 fatty acid-derived eicosanoids. Based on
the findings from this study, consumption of a diet rich
in n-3 fatty acids from marine sources is beneficial
against the deleterious effects of Gram negative bacterial
infection.
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